Forecast & Rating4 analysts currently cover Elicio Therapeutics, of which 3 give a positive rating. The average price target is $16.50, about 704.9% upside from the current price of $2.05. Coverage is limited, so the data is for reference only. Data as of Aug 20, 2026; this does not constitute investment advice.
Aug 20, 2026Price forecast
$16.50704.88%
Forecast & RatingBuy
4analysts
- Strong buy75.00%
- Buy0.00%
- Hold25.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 7, 2026
Forecast met70.0%
Stock price$2.05
Avg. target$15.5
High target$18
Low target$13
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.